donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
GMED Globus Medical
66.520
-0.540-0.81%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue
5.03% 263.65M 1.41% 230.55M 21.43% 958.1M 7.1% 250.02M
Operating revenue
5.03% 263.65M 1.41% 230.55M 21.43% 958.1M 7.1% 250.02M
Cost of revenue
7.24% 68.47M 7.52% 59.17M 10.01% 239.22M 1.54% 61.8M
Gross profit
4.28% 195.18M -0.54% 171.38M 25.77% 718.88M 9.06% 188.23M
Operating expense
0.85% 128.51M 4.32% 122.67M 14.89% 524.02M 44.67% 162.14M
Selling and administrative expenses
-0.5% 106.72M 2.92% 100.75M 15.05% 408.15M 15.77% 106.56M
Research and development costs
11.89% 17.4M 16.67% 17.41M 15.18% 97.35M 234.77% 51.02M
Depreciation amortization depletion
-4.98% 4.39M -5.49% 4.51M 10.07% 18.53M -4.85% 4.56M
-Depreciation and amortization
-4.98% 4.39M -5.49% 4.51M 10.07% 18.53M -4.85% 4.56M
Operating profit
11.59% 66.67M -11% 48.71M 68.75% 194.86M -56.89% 26.09M
Net non-operating interest income expense
-2.56% 2.48M -6.23% 2.54M -33.36% 9.3M -34.34% 1.94M
Total other finance cost
2.56% -2.48M 6.23% -2.54M 33.36% -9.3M 34.34% -1.94M
Other net income (expense)
110.42% 1.39M -857.32% -2.36M -573.7% -23.75M -555.84% -8.2M
Gain on sale of security
-629.67% -1.11M -39.64% -391K -410.04% -1.42M -186.15% -454K
Special income (charges)
107.96% 1.1M -1158.33% -2.27M -467.1% -22.91M -299.34% -7.89M
-Less:Restructuring and merger&acquisition
-107.96% -1.1M -127.74% -76K 321.44% 16.98M 14.52% 2.48M
-Less:Other special charges
-- -- 2590.43% 2.34M 65688.89% 5.92M 2977.66% 5.41M
Other non- operating income (expenses)
354.4% 1.4M 40.65% 301K -26.86% 580K -27.78% 143K
Income before tax
44.16% 70.54M -14.51% 48.9M 43.3% 180.41M -68.13% 19.83M
Income tax
115.89% 15.95M -8.86% 10.81M 32.19% 31.22M -48.98% 4.72M
Net income
31.4% 54.59M -15.98% 38.08M 45.86% 149.19M -71.47% 15.11M
Net income continuous Operations
31.4% 54.59M -15.98% 38.08M 45.86% 149.19M -71.47% 15.11M
Minority interest income
Net income attributable to the parent company
31.4% 54.59M -15.98% 38.08M 45.86% 149.19M -71.47% 15.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.4% 54.59M -15.98% 38.08M 45.86% 149.19M -71.47% 15.11M
Basic earnings per share
31.71% 0.54 -17.78% 0.37 42.31% 1.48 -72.22% 0.15
Diluted earnings per share
32.5% 0.53 -15.91% 0.37 42.57% 1.44 -73.08% 0.14
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
----Unqualified Opinion--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
CEO: --
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...